Serological response to SARS-COV-2 vaccines in patients with multiple sclerosis in Argentina

Rojas, Juan I.; Alonso, Ricardo; Cabrera, Mariela; Carnero Contentti, Edgar; Cristiano, Edgardo; Deri, Norma; Hryb, Javier; Lopez, Pablo; Luetic, Geraldine; Patrucco, Liliana; Tkachuk, Veronica; Ysrraelit, María C.; Zanga, Gisela; Cruces, Leonel; Turk, Gabriela; Longueira, Yesica; Laufer, Natalia; Nuñez, Sebastian.
Medicina (B.Aires) ; 83(3): 358-365, ago. 2023. graf
Artículo en Inglés | LILACS-Express | ID: biblio-1506689

Documentos relacionados

  1. Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina.
  2. National survey for pediatricians in Argentina: Vaccination in daily practice, perception of knowledge and barriers.
  3. Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod.
  4. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults.
  5. Treatment-Resistant Depression in Argentina: results from a longitudinal analysis of the TRAL Study
  6. Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
  7. El sendero hacia la vacuna contra el SARS-CoV-2
  8. Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
  9. Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective study.
  10. Encuesta nacional para pediatras de Argentina: vacunación en la práctica diaria, percepción de conocimientos y barreras